Makena Follows Avastin’s Path With US FDA Hearing On Accelerated Approval Withdrawal

 
• By Sue Sutter
Footsteps in sand
Covis is following Genentech's footsteps on a route that will take the Makena sponsor to a public hearing under the accelerated approval regulations. • Source: Alamy

More from Review Pathways

More from Pathways & Standards